Bradsher Neal C — SEC insider filings
SEC reporting owner CIK 1278388. 66 insider filings on record with FilingPulse; latest filed 2026-11-19.
Transaction summary — filings shown
Covers the 50 most recent of 66 filings on record, filed 2021-07-01 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 204 legs across 39 filings — 70,523,227 shares, $251,451,369 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: purchase of 797,486 shares @ $27.86 ($22,218,837) in STAAR SURGICAL CO, filed 2025-11-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| STAAR SURGICAL CO (STAA) | Director, 10% owner | 30 | 164 legs · 7,531,835 sh · $187,058,996 | — | 6 |
| Insight Molecular Diagnostics Inc. (IMDX) | 10% owner | 10 | 28 legs · 46,435,779 sh · $49,304,006 | — | 14 |
| Lineage Cell Therapeutics, Inc. (LCTX) | Director, 10% owner | 10 | 12 legs · 16,555,613 sh · $15,088,368 | — | 8 |
Insider filings — Bradsher Neal C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-19 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 1,000,000 @ $0.77 · Purchase (P): 0 @ $0 | EDGAR |
| 2026-11-19 | 4 | Insight Molecular Diagnostics Inc. (IMDX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 3,428,571 @ $1.75 · Purchase (P): 0 @ $0 | EDGAR |
| 2026-07-02 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | STAAR SURGICAL CO (STAA) | Grant/award (A): 11,145 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | Insight Molecular Diagnostics Inc. (IMDX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 280,381 @ $3.50 · Purchase (P): 0 @ $0 · Purchase (P): 38,880 @ $3.53 · Purchase (P): 0 @ $0 · Purchase (P): 250,923 @ $3.64 · Purchase (P): 0 @ $0 | EDGAR |
| 2026-04-20 | 4 | Insight Molecular Diagnostics Inc. (IMDX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 102,057 @ $3.45 · Purchase (P): 0 @ $0 · Purchase (P): 40,114 @ $3.57 · Purchase (P): 0 @ $0 · Purchase (P): 40,690 @ $3.88 · Purchase (P): 0 @ $0 | EDGAR |
| 2026-03-13 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 54,764 @ $17.52 · Purchase (P): 0 @ $0 · Purchase (P): 299,432 @ $18.12 · Purchase (P): 0 @ $0 · Purchase (P): 316,017 @ $18.61 · Purchase (P): 0 @ $0 | EDGAR |
| 2026-03-10 | 4 | STAAR SURGICAL CO (STAA) | Grant/award (A): 7,524 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | Insight Molecular Diagnostics Inc. (IMDX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 521,739 @ $5.75 · Purchase (P): 0 @ $0 | EDGAR |
| 2026-01-13 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 27,485 @ $22.05 · Purchase (P): 0 @ $0 | EDGAR |
| 2026-01-08 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 186,946 @ $21.01 · Purchase (P): 0 @ $0 · Purchase (P): 150,000 @ $22.38 · Purchase (P): 0 @ $0 · Purchase (P): 66,467 @ $22.00 · Purchase (P): 0 @ $0 · +2 more | EDGAR |
| 2025-11-21 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 309,132 @ $26.42 · Purchase (P): 0 @ $0 · Purchase (P): 393,382 @ $27.14 · Purchase (P): 0 @ $0 · Purchase (P): 797,486 @ $27.86 · Purchase (P): 0 @ $0 | EDGAR |
| 2025-07-03 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-04-10 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 166,527 @ $15.28 · Purchase (P): 0 @ $0 · Purchase (P): 11,600 @ $15.95 · Purchase (P): 0 @ $0 · Purchase (P): 8,200 @ $15.08 · Purchase (P): 0 @ $0 · +2 more | EDGAR |
| 2025-04-07 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 209,535 @ $16.97 · Purchase (P): 0 @ $0 · Purchase (P): 492,631 @ $15.90 · Purchase (P): 0 @ $0 · Purchase (P): 5,000 @ $16.46 · Purchase (P): 0 @ $0 · +4 more | EDGAR |
| 2025-04-02 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 22,189 @ $17.46 · Purchase (P): 0 @ $0 · Purchase (P): 31,780 @ $17.43 · Purchase (P): 0 @ $0 | EDGAR |
| 2025-03-28 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 101,633 @ $17.50 · Purchase (P): 0 @ $0 · Purchase (P): 3,620 @ $17.48 · Purchase (P): 0 @ $0 · Purchase (P): 8,131 @ $17.47 · Purchase (P): 0 @ $0 | EDGAR |
| 2025-03-25 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 102,400 @ $17.74 · Purchase (P): 0 @ $0 · Purchase (P): 34,296 @ $17.44 · Purchase (P): 0 @ $0 | EDGAR |
| 2025-03-20 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 58,734 @ $17.41 · Purchase (P): 0 @ $0 · Purchase (P): 34,390 @ $17.76 · Purchase (P): 0 @ $0 · Purchase (P): 108,720 @ $17.96 · Purchase (P): 0 @ $0 | EDGAR |
| 2025-03-06 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 17,528 @ $17.02 · Purchase (P): 0 @ $0 · Purchase (P): 10,425 @ $17.61 · Purchase (P): 0 @ $0 | EDGAR |
| 2025-03-03 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 114,713 @ $16.44 · Purchase (P): 0 @ $0 · Purchase (P): 144,603 @ $17.52 · Purchase (P): 0 @ $0 · Purchase (P): 153,142 @ $17.45 · Purchase (P): 0 @ $0 · +6 more | EDGAR |
| 2025-02-14 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 82,730 @ $13.99 · Purchase (P): 0 @ $0 · Purchase (P): 72,017 @ $14.90 · Purchase (P): 0 @ $0 · Purchase (P): 104,869 @ $15.77 · Purchase (P): 0 @ $0 · +4 more | EDGAR |
| 2025-02-10 | 4 | Oncocyte Corp (OCX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 660,207 @ $2.05 · Purchase (P): 0 @ $0 · Purchase (P): 4,505,488 @ $2.05 · Purchase (P): 0 @ $0 | EDGAR |
| 2025-01-28 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 7,894,737 @ $0.76 · Purchase (P): 0 @ $0 · Purchase (P): 7,894,737 (derivative) @ $0 · Purchase (P): 0 (derivative) @ $0 | EDGAR |
| 2025-01-16 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 21,155 @ $21.46 · Purchase (P): 0 @ $0 · Purchase (P): 8,221 @ $21.50 · Purchase (P): 0 @ $0 | EDGAR |
| 2024-12-18 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 46,220 @ $24.15 · Purchase (P): 0 @ $0 · Purchase (P): 7,280 @ $24.83 · Purchase (P): 0 @ $0 · Purchase (P): 3,700 @ $24.58 · Purchase (P): 0 @ $0 · +2 more | EDGAR |
| 2024-10-04 | 4 | Oncocyte Corp (OCX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 1,315,339 @ $2.95 · Purchase (P): 0 @ $0 | EDGAR |
| 2024-07-03 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 1 @ $42.56 · Purchase (P): 0 @ $0 | EDGAR |
| 2024-04-15 | 4 | Oncocyte Corp (OCX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 2,420,000 @ $2.92 · Purchase (P): 0 @ $0 · Other (J): 2,941.18 (derivative) · Other (J): 0 (derivative) | EDGAR |
| 2024-02-08 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 6,730,770 @ $1.04 · Purchase (P): 0 @ $0 | EDGAR |
| 2024-01-10 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 4,042 @ $27.11 · Purchase (P): 0 @ $0 | EDGAR |
| 2024-01-05 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 6,573 @ $28.93 · Purchase (P): 0 @ $0 · Purchase (P): 63,246 @ $28.91 · Purchase (P): 0 @ $0 · Purchase (P): 156,634 @ $28.48 · Purchase (P): 0 @ $0 · +2 more | EDGAR |
| 2023-11-30 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 91,944 @ $31.84 · Purchase (P): 0 @ $0 · Purchase (P): 5,040 @ $32.00 · Purchase (P): 0 @ $0 · Purchase (P): 157,473 @ $31.38 · Purchase (P): 0 @ $0 · +4 more | EDGAR |
| 2023-11-14 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 34,320 @ $32.73 · Purchase (P): 0 @ $0 · Purchase (P): 507 @ $33.04 · Purchase (P): 0 @ $0 | EDGAR |
| 2023-11-09 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 9,731 @ $34.03 · Purchase (P): 0 @ $0 · Purchase (P): 139,409 @ $33.71 · Purchase (P): 0 @ $0 · Purchase (P): 119,390 @ $32.99 · Purchase (P): 0 @ $0 · +2 more | EDGAR |
| 2023-11-06 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 87,849 @ $35.64 · Purchase (P): 0 @ $0 · Purchase (P): 56,178 @ $36.03 · Purchase (P): 0 @ $0 · Purchase (P): 520 @ $36.06 · Purchase (P): 0 @ $0 · +2 more | EDGAR |
| 2023-10-06 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 32,523 @ $37.93 · Purchase (P): 0 @ $0 · Purchase (P): 97,474 @ $37.92 · Purchase (P): 0 @ $0 · Purchase (P): 75,299 @ $37.62 · Purchase (P): 0 @ $0 | EDGAR |
| 2023-09-21 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 4,490 @ $40.89 · Purchase (P): 0 @ $0 · Purchase (P): 132,079 @ $40.67 · Purchase (P): 0 @ $0 · Purchase (P): 154,814 @ $39.62 · Purchase (P): 0 @ $0 | EDGAR |
| 2023-09-07 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 20,144 @ $41.87 · Purchase (P): 0 @ $0 · Purchase (P): 108,944 @ $41.43 · Purchase (P): 0 @ $0 · Purchase (P): 60,874 @ $41.26 · Purchase (P): 0 @ $0 | EDGAR |
| 2023-07-03 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-04-05 | 4 | Oncocyte Corp (OCX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 26,827,638 @ $0.30 · Purchase (P): 0 @ $0 | EDGAR |
| 2022-12-29 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 51,985 @ $47.91 · Purchase (P): 0 @ $0 · Purchase (P): 100,000 @ $46.98 · Purchase (P): 0 @ $0 · Purchase (P): 39,090 @ $47.93 · Purchase (P): 0 @ $0 | EDGAR |
| 2022-07-06 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2022-04-15 | 4 | Oncocyte Corp (OCX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 6,003,752 @ $1.33 · Purchase (P): 0 @ $0 · Grant/award (A): 5,882.35 (derivative) · Grant/award (A): 0 (derivative) · Grant/award (A): 6,003,752 (derivative) · Grant/award (A): 0 (derivative) | EDGAR |
| 2022-03-25 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Purchase (P): 260,106 @ $1.37 · Purchase (P): 0 @ $0 · Purchase (P): 200,000 @ $1.42 · Purchase (P): 0 @ $0 · Purchase (P): 470,000 @ $1.44 · Purchase (P): 0 @ $0 | EDGAR |
| 2021-10-01 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Other (J): 71,577 @ $0 · Other (J): 0 @ $0 | EDGAR |
| 2021-09-24 | 4 | Oncocyte Corp (OCX) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Option exercise/expiry (X): 573,461 @ $3.15 · Option exercise/expiry (X): 0 @ $0 · Disposition to issuer (D): 573,461 (derivative) · Disposition to issuer (D): 0 (derivative) · Grant/award (A): 573,461 (derivative) · Grant/award (A): 0 (derivative) · +2 more | EDGAR |
| 2021-07-02 | 4 | STAAR SURGICAL CO (STAA) jointly with BROADWOOD PARTNERS, L.P., BROADWOOD CAPITAL INC | Other (J): 655 @ $0 · Other (J): 0 @ $0 | EDGAR |
| 2021-07-01 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1278388 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs